The NPCD device was more effective than an APCD and resulted in greater adherence to self-care interventions and greater patient satisfaction.īreast cancer-related lymphedema Cancer survivorship Medical device Quality of life.Ĭopyright © 2022 The Authors. The results have shown that the novel NPCD is an effective maintenance treatment for reducing the limb volume in patients with breast cancer-related lymphedema. However, there is no consensus on the frequency or treatment parameters for IPC devices. The patients indicated that use of the NPCD facilitated exercise and was convenient for travel. ABSTRACT Intermittent Pneumatic Compression (IPC) therapy is an effective modality to reduce the volume of the lymphedematous limbs alone or in conjunction with other modalities of therapy such as decongestive therapy. 001), and greater satisfaction with the device (90% vs 14% P <. 001), significantly greater mean improvements in quality of life scores, greater adherence (95.6% vs 49.8% P <. Compared with the APCD, the NPCD was associated with a greater mean reduction in the limb edema volume (64.6% vs 27.7% P <. The patients used the randomly assigned initial device for 28 days with a 4-week washout period before a comparable 28-day use of the second device.ĭata from 50 adult women with unilateral breast cancer-related lymphedema were analyzed. compression for breast cancer-related lymphedema treatment in the home. Material and methods: Eligible patients had completed treatment for HNC, were disease free, and had lymphedema at enrollment. A randomized, wait-list controlled trial was undertaken to evaluate an APCD in post-treatment HNC patients with lymphedema. The patients had been randomized to either the NPCD or a commercially available APCD. only 1 patient using the pneumatic compression treatment device twice daily as. Advanced pneumatic compression devices (APCD) may address these issues. We evaluated the safety and efficacy of a novel nonpneumatic compression device (NPCD) for treating lymphedema vs an APCD.Ī randomized, crossover head-to-head investigation was performed at five U.S. However, adherence to self-care has been poor, and APCDs require patients to be immobile during treatment. Brief Summary: This is a research study to compare the efficacy of aspirin (acetylsalicylic acid) and pneumatic compression devices versus enoxaparin (also known as Lovenox) and pneumatic compression devices in preventing deep vein thrombosis in patients with pelvic and lower extremity malignant tumors and undergoing surgery. Advanced pneumatic compression devices (APCDs) have been shown to be an effective intervention for lymphedema when used as part of a self-care maintenance treatment regimen.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |